Skip to content

Clinical trials

Phase 2 Neoplasms, Glandular and Epithelial trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms, Glandular and Epithelial Phase: Phase 2 Country / region: China Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20202
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Xiaoxiang Chen2
Qingdao Central Hospital1
Shandong Cancer Hospital and Institute1
Wenjun Cheng1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms, Glandular and Epithelial5
Carcinoma4
Neoplasms by Histologic Type4
Neoplasms by Site4
Carcinoma, Ovarian Epithelial3
Genital Diseases, Female3
Genital Neoplasms, Female3
Ovarian Diseases3
Ovarian Neoplasms3
Adenocarcinoma2

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.